Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform recommendation. As of February 19, 2025, the average one-year price ...

With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.

Cell therapy developer CARGO Therapeutics (NASDAQ:CRGX) traded higher on Tuesday after William Blair launched its coverage with ... “We believe near-term initiatives to expand CAR-T access ...

Shares of NASDAQ:SNEX opened at $78.60 on Wednesday. The company has a market cap of $3.78 billion, a PE ratio of 9.39 and a beta of 0.77. StoneX Group has a fifty-two week low of $42.69 and a ...

William Blair sees room for margin expansion in fiscal 2027 as revenue growth accelerates, retention improves, and PLG initiatives gain traction. While macro sensitivity and competition remain ...

Kennedy highlighted that since William Blair initiated coverage on Nayax ... These recent developments reflect Nayax’s strategic initiatives to expand its market presence and improve its ...

Shares of NASDAQ SKYE opened at $2.85 on Friday. The company’s fifty day moving average price is $3.02 and its 200 day moving average price is $3.14. Skye Bioscience has a 1 year low of $2.31 ...

On Monday, William Blair reaffirmed a Market Perform rating ... sequential sales growth throughout the year. The company's initiatives, if successful, may set Kenvue on a course to reach its ...